Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
8.19
+0.63 (8.33%)
At close: Oct 9, 2026, 4:00 PM EDT
8.03
-0.16 (-1.95%)
After-hours: Oct 9, 2026, 7:31 PM EDT
Immunic Market Cap
Immunic has a market cap or net worth of $111.75 million as of October 9, 2026. It is the 24,669th most valuable company in the world and the 4,033rd biggest in the United States. Its market cap has increased by 26.21% in one year.
Market Cap
111.75M
Enterprise Value
-42.78M
1-Year Change
26.21%
Global Rank
Country Rank
#4,033 United States
Category
ChartMarket Cap Chart
Since April 15, 2019, Immunic's market cap has decreased from $243.61M to $111.75M, a decrease of -54.13%. That is a compound annual growth rate of -9.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 111.75M | 74.07% |
| Dec 31, 2025 | 64.20M | -28.73% |
| Dec 31, 2024 | 90.08M | 33.02% |
| Dec 29, 2023 | 67.72M | 9.04% |
| Dec 30, 2022 | 62.10M | -75.28% |
| Dec 31, 2021 | 251.21M | -20.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 15, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Coya Therapeutics | 116.35M |
| Unicycive Therapeutics | 114.49M |
| Humacyte | 114.40M |
| Inovio Pharmaceuticals | 113.22M |
| Conexeu Sciences | 112.83M |
| LENZ Therapeutics | 112.17M |
| Rani Therapeutics Holdings | 111.78M |
| Genelux | 110.69M |